TrialRespiratory research2021

Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, phase III study.

Hans Klose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.